Argipressin — Drug Intelligence | 13 EU Trials

Filter these 13 trials by condition, phase, country and more.

Open in Search →

13 Registered trials

6 Recruiting

4 Completed trials

10 Sponsors

17 Countries

Phase III

Phase IV

Phase III: 10 Phase II: 1 Phase IV: 2

Oversight events:

1 temporary halt across 1 trial

View oversight register →

Indications tested

Septic shock 2 Cardiac arrest 1 Pulmonary hypertension 1 Small cell lung cancer limited stage 1 Pulmonary endarterectomy 1 Pulmonary arterial hypertension 1 Small cell lung cancer extensive stage 1 Norepinephrine 1

Sponsors using this IMP

Amgen Inc. 2 Assistance Publique Hopitaux De Paris 2 Tiohundra AB 2 Azienda Unita Sanitaria Locale Di Bologna 1 Centre Hospitalier Regional De Marseille 1 Centre Hospitalier Universitaire De Dijon 1 Centre Hospitalier Universitaire Dijon Bourgogne 1 Fondation Hopital Saint Joseph 1 Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting 1 Vaestra Goetalandsregionen 1

All trials

13 total

Effect of vasopressin versus norepinephrine on post-operative mean pulmonary arterial pressure following pulmonary endarterectomy surgery, a… Pending

2025-525153-39-00 Phase III 1 country Fondation Hopital Saint Joseph
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited‑Stage Small‑Cell Lung Cancer (DeLLphi-306) Recruiting

2023-506235-15-00 Phase III 12 countries Amgen Inc.
Efficacy of early Argipressin (arginine vasopressin) in the management of intensive care patients with norepinephrine-refractory vasoplegic … Recruiting

2024-516639-28-00 Phase III 1 country Centre Hospitalier Universitaire De Dijon
Systematic Adjunction of Vasopressine in hyperkinetic Septic Shock patients: a prospective, randomized, double blind study. Recruiting

2024-513401-31-00 Phase III 1 country Centre Hospitalier Regional De Marseille
Effect of low-dose arginine-vasopressin supplementation on post-transplant Acute Kidney Injury after liver transplantation - AVENIR Trial Recruiting

2023-506512-40-00 Phase III 1 country Assistance Publique Hopitaux De Paris
HiPRESS study Recruiting

2024-513598-33-00 Phase IV 1 country Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Renal Outcomes in the early use of vasopressin in the treatment of septic shock Recruiting

2023-509071-16-00 Phase IV 1 country Azienda Unita Sanitaria Locale Di Bologna
Study Comparing Tarlatamab and Durvalumab versus Durvalumab Alone in First Line ES-SCLC Following Platinum, Etoposide and Durvalumab (DeLLph… Ended

2023-505989-29-00 Phase III 16 countries Amgen Inc.
Evaluating the superiority of VAsopressin versus NOradrenaline in the management of the renal risk patient undergoing cardiac surgery with e… Ended

2022-500419-38-00 Phase III 1 country Centre Hospitalier Universitaire Dijon Bourgogne
Hydrocorticose and vasopressin in post-resuscitation syndrome Ended

2024-516373-77-00 Phase III 1 country Assistance Publique Hopitaux De Paris
VAsopressin and STeroids in addition to Adrenaline in cardiac arrest - a randomized clinical trial. VAST-A Halted

2025-521283-35-00 Phase III 1 country Tiohundra AB
Influence of Argipressin on blood loss during liver resection; a double-blinded, randomized, placebo-controlled trial (ARG-01) Ended

2024-514332-25-00 Phase II 1 country Vaestra Goetalandsregionen
VAsopressin and STeroids in addition to Adrenaline in cardiac arrest - a randomized clinical trial. VAST-A Expired

2022-500137-89-00 Phase III 1 country Tiohundra AB

Showing 1–13 of 13 trials

← All drugs A–Z